Viking Therapeutics Inc (VKTX) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

29 /100 composite · 6 modules · general weight set

Quality 1
Growth 24
Balance sheet 63
Cash quality 43
Capital allocation 13
Momentum 50

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

27.37 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

1/7 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

Continue: the VKTX chart & overview

FAQ · from the current data · as of 2026-08-06

Quick answers

What is Viking Therapeutics Inc's Closelook quality reading?

The composite reads 29/100 across 6 modules, as of 2026-08-06: quality 1, growth 24, balance sheet 63, cash quality 43, capital allocation 13, momentum 50. Closelook scores are research diary readings, not ratings or investment advice.

What is Viking Therapeutics Inc's Altman Z-Score?

27.37, which sits in the safe zone (above 2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Viking Therapeutics Inc's Piotroski F-Score?

1 of 7, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.